Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: Conference, Product/Service, Award

Krishnan Suthanthiran, President & Founder of TeamBest Companies & Best Cure Foundation, Presents the AAPM Best Award to its 2019 Recipients in San Antonio, Texas, at the AAPM Annual Meeting


On July 15th, Krishnan Suthanthiran, President & Founder of TeamBest Companies and Best Cure Foundation, presented the AAPM Best Award to the 2019 recipients at the Annual Meeting of the American Association of Physicists in Medicine (AAPM) taking place in San Antonio, Texas, USA July 14?17, 2019. The recipients of this year's award are Jamison L. Brooks (University of Minnesota), Davide Brivio Ph.D. (Brigham and Women's Hospital), Jina Chang Ph.D. (University of Pittsburgh Medical Center), Esther M. Vicente Ph.D. (University of Maryland School of Medicine) and Chuang Wang (Memorial Sloan Kettering Cancer Center).

TeamBest Companies provide such awards, either in conjunction with professional societies or independently, to support and encourage excellent ethical medical care to patients, by offering opportunities for a range of medical professionals, residents, interns and students to continuously learn and train.

Over the past 50 years, Mr. Suthanthiran has focused on a Total Healthtm Approach (Prevention, Early Detection and Effective Treatment for Total Cure) in Oncology, Cardiology and other major diseases through a range of companies, education and training, to offer technologies and products for effective treatment management of patients. Having lost his father to cancer in 1968, he has established a number of non-profit foundations, such as Brachytherapy Research & Educational Foundation (BREF), and Best Cure Foundation, and has been supporting them personally for more than two decades.

Best Cure Foundation's three major goals are:

  1. Provide purified drinking water and affordable sewer systems to every part of the world by the end of next decade, 2030.
  2. Establish a Hub-and-Spoke Model of Global Healthcare System (unlike the current Disease Care System), through Express and Mobile Clinics, linked to General and Super Specialty Medical Centers; to reduce the death and suffering from Cardiac, Cancer, Diabetes and other major diseases by 50% by the end of the next decade, 2030.
  3. Using its division 3E ? Education, Empowerment & Equality, to promote Women and under-privileged citizens of the world.

TeamBest Companies are exhibiting at the AAPM 2019 Annual Meeting at the following Large Island Booth numbers: 1024, 1124, 1222, 1322, 1130, 1230 and 1328.

For more information about TeamBest Companies and how to join Best Cure Foundation's efforts, please visit www.teambest.com and www.bestcure.md.

For more information about Krishnan Suthanthiran, please visit his bio page at http://www.teambest.com/about_bio.html.

U.S. Office (HQ): 7643 Fullerton Road, Springfield, Virginia 22153 USA


These press releases may also interest you

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...

at 02:54
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...

at 02:50
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...



News published on and distributed by: